| Financial Year |
March 31 2023 |
| Monetary Funds |
535,049,843.40 |
| Held-for-trading Financial Assets |
134,100,000.00 |
| Notes Receivable |
43,725,673.59 |
| Accounts Receivable |
370,944,322.93 |
| Advances to Suppliers |
44,675,800.51 |
| Other Receivables |
13,022,864.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
114,248,769.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
220,000.00 |
| Other Current Assets |
28,062,308.45 |
| Total Current Assets |
1,284,049,582.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,850,000.00 |
| Long-term Equity Investment |
59,873,917.27 |
| Investment Properties |
33,789,522.09 |
| Fixed Assetes |
146,273,696.83 |
| Under-construction Projects |
187,041,267.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
417,311,183.38 |
| R&D expenses |
-- |
| Goodwill |
135,885,585.66 |
| Long-Term Deferred and Prepaid Expenses |
12,936,497.35 |
| Deferred Income Tax Assets |
41,904,021.78 |
| Other Non-Current Assets |
49,109,238.67 |
| Sub-Total of Non-Current Assets |
1,318,821,743.47 |
| Total Assets |
2,602,871,325.86 |
| Short-Term Loans |
1,158,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
78,754,042.02 |
| Accounts Received In Advance |
5,466,430.16 |
| Employee Compensation Payable |
53,971,116.14 |
| Taxes Payable |
38,501,823.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,909,544.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,122,423.18 |
| Other Current Liabilities |
407,341.85 |
| Sub-Total of Current Liabilities |
251,195,581.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
42,311,070.40 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,020,337.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
483,154,867.76 |
| Total Liabilities |
734,350,448.95 |
| Paid-In Capital(Or Share Stock) |
263,053,100.00 |
| Capital Surplus |
672,825,722.85 |
| Surplus Reserve |
75,531,444.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
677,491,355.72 |
| Minority Stockholder's Interest |
302,955,303.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,565,565,573.37 |
| Owner's Equity（Stockholder's Equity） |
1,868,520,876.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,602,871,325.86 |
